Bedside ultraportable ultrasound system that provides all ultrasound tools for non-invasive liver assessment

Reliable chronic liver disease assessment at the point of care

Hepatoscope is an ultraportable device that provides all ultrasound tools needed for non-invasive liver assessment by healthcare professionals. It offers real-time image guidance for the precise measurement of ultrasound parameters related to liver fibrosis and steatosis severity.

Hepatoscope is the only ultraportable system with 2D transient elastography (2DTE), ensuring robust and reproducible measurements of liver stiffness under image guidance. Quantitative ultrasound parameters (Q.US) related to steatosis, i.e. ultrasound attenuation (ATT) and speed of sound (SOS), are extracted from large 2D areas.

How does Hepatoscope is working ?

Clinical applications

Hepatoscope can be used for the triage, diagnosis and monitoring of adult and pediatric patients with liver disease, as part of their clinical management.

Benefits of Hepatoscope

Clinical Practice Guidelines

The non-invasive assessment of liver status by ultrasound tools has been recommended globally, by several specialized medical societies, for both steatosis and fibrosis severity.

Two-dimensional Transient Elastography (2DTE)

  • Assess and measure in real time tissue stiffness, including liver and spleen, under high quality image guidance
  • Allow your patients to breathe normally during measurements to ensure a larger volume of liver
    sampled, while still avoiding the right lung, the gallbladder, large vessels and liver lesions.
  • Improve the accuracy and the reliability of LSM thanks to 2D tracking of shear waves, and increase the reproducibility of LSM
  •  Automatically save prospectively 10 values of liver stiffness of high enough quality with the press of a single button
  • Benefit from 1 single probe for all patients, and from a specifically designed user interface to streamline liver exams in a few minutes

Perform Liver Stiffness Measurement (LSM) under image guidance

Quantitative Ultrasound: assess liver steatosis quantitatively with reliable ultrasound parameters

  • Simultaneously assess and measure in real time 3 ultrasound parameters related to liver steatosis: attenuation (ATT), backscatter coefficient (BSC) and speed of sound (SOS)
  • Allow your patients to breathe normally during measurements to ensure a larger volume of liver sampled
  • Use real-time image guidance to avoid the right lung, the gallbladder, large vessels and liver lesions
  • Benefit from simultaneous measurements and from streamlined exam workflow in just a few minutes
  • Automatically save prospectively 10 values of each ATT, BSC and SOS of high enough quality with the press of a single button

If you are interested in our product and want to learn more, please enter your contact details so that we can answer you.

6 + 1 =

Stay tuned!

You have Successfully Subscribed!

Your personal data will be sent and processed by E-Scopics in order to reply to your message and to provide you with general information on the company and its products. Under the General Data Protection Regulation (GDPR), processing of such information is necessary for the purposes of the legitimate interests pursued by E-Scopics. E-Scopics keeps your personal data for three years and will never share your data with commercial partners. Authorised personnel of E-Scopics’ processors may have access to your data. In accordance with the GDPR and the French Data Protection Act (Loi n° 78-17 du 6 janvier 1978 relative à l’informatique, aux fichiers et aux libertés), you have the right to request access to and rectification or erasure of personal data or restriction of processing or to object to processing. You can do this at any time by contacting E-Scopics’ person responsible for data protection at the following address: dpo@e-scopics.com. If you have any concerns about our use of your personal information, you can make a complaint to the CNIL.

Regulatory informations:
USA: cleared by the FDA under K213102
Europe: under submission for MDR 2017/745